Treatment Verification Rates for Chlamydia and Gonorrhea Region II IPP Advisory Meeting May 31, 2006 Kelly Opdyke, MPH Cicatelli Associates Inc.
Region II IPP Strategic Plan 2005-2009 PRIORITY 3: Improve Appropriate and Timely Treatment for Persons Diagnosed with Chlamydial Infection and their Partners GOAL: 100% of Clients will be treated within 30 days of diagnosis. OBJECTIVE 3B: Increase by 10% annually the number of positive clients being treated within 30 days of specimen collection.
CDC Performance Measures 2006 Measure 1 (IPP-CS1) Among clients of IPP family planning clinics, the proportion of women with positive CT tests that are treated within 14 and 30 days of the date of specimen collection. Measure 2 (IPP-CS1) Among clients of IPP family planning clinics, the proportion of women with positive GC tests that are treated within 14 and 30 days of the date of specimen collection.
Treated for Chlamydia within 14 days (IPP-CS1) Note: No data available for USVI
Treated for Chlamydia within 30 days (IPP-CS1) Note: No data available for USVI
Treated for Gonorrhea within 14 days (IPP-CS2) Note: No data available for USVI
Treated for Gonorrhea within 30 days (IPP-CS2) Note: No data available for USVI
Questions/Considerations 1) What data sources are available to Projects to monitor timely treatment? What are the limitations of the data? What are the opportunities for/obstacles to providing timely treatment?